Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05635357 · ClinicalTrials.gov registry record
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Anastrozole vs Exemestane/Letrozole
A clinical trial of Breast Cancer, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 16,989
- Enrollment target
- 1
- Study location
NCT05635357 is a study of Breast Cancer that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 16,989 participants, above the 2,789-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (509% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05635357, a study of Breast Cancer, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 16,989 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to evaluate the comparative risk of dementia/Alzheimer's disease onset between patients treated with medications that target specific metabolic pathways and patients treated with alternative medications for the same indication.
Conditions Studied
Interventions
- DRUG Anastrozole
- DRUG Exemestane/Letrozole
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16,989 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2023-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05635357
The ClinicalTrials.gov registry entry for NCT05635357 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16,989 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,789-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (509% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Anastrozole is the first listed.
NCT05635357 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05635357 about?
NCT05635357 is a clinical study titled "Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Anastrozole vs Exemestane/Letrozole". This study aims to evaluate the comparative risk of dementia/Alzheimer's disease onset between patients treated with medications that target specific metabolic pathways and patients treated with alternative medications for the same indication.
What is the current status of trial NCT05635357?
This trial is currently completed. The enrollment target is 16,989 participants. The study started on 2022-11-01. Estimated completion is 2023-12-31.
What conditions does trial NCT05635357 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT05635357?
The interventions under investigation include: Anastrozole (DRUG), Exemestane/Letrozole (DRUG).
Who is sponsoring clinical trial NCT05635357?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05635357 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.